CT Guided Biopsies

CT-Guided Biopsy — Lesson Overview

What Is a CT-Guided Biopsy?

A CT-guided biopsy is a minimally invasive percutaneous procedure in which computed tomography imaging is used to plan and direct needle placement into a target lesion that is either too deep, too small, or insufficiently visualized by ultrasound to be safely sampled under real-time sonographic guidance. By providing precise cross-sectional anatomic detail, CT allows the interventional radiologist to identify an optimal needle trajectory, measure the exact depth and angulation required to reach the target, and confirm needle tip position within the lesion before tissue is obtained.

CT-guided biopsy has become the preferred modality for lesions involving the lung, mediastinum, retroperitoneum, pelvis, spine, and deep abdominal organs — territories where overlying bowel gas, bone, or depth limit ultrasound visualization. Unlike ultrasound, CT does not provide continuous real-time needle visualization; instead, the operator advances the needle in deliberate incremental steps, acquiring confirmatory CT images at each stage to verify trajectory before proceeding deeper. This intermittent imaging approach demands precise pre-procedural planning, disciplined technique, and a thorough understanding of the three-dimensional anatomy surrounding the target.

In interventional radiology, CT-guided biopsy is one of the highest-volume diagnostic procedures performed and plays a pivotal role in the workup of pulmonary nodules, retroperitoneal masses, hepatic lesions not visible on ultrasound, osseous lesions, and adrenal masses. Advances such as CT fluoroscopy, cone-beam CT, and electromagnetic navigation have further refined the precision and safety of these procedures, allowing access to increasingly challenging targets with reduced complication rates and improved diagnostic yield.

What You'll Learn in This Video

By the end of this lesson, you will be able to:

• Explain the role of CT-guided biopsy in the diagnostic algorithm for deep or poorly visualized lesions, and understand when CT guidance is chosen over ultrasound, MRI, or surgical biopsy based on lesion location, depth, surrounding anatomy, and visibility on each modality

• Identify the indications and contraindications for CT-guided biopsy, including lesion size thresholds, location-specific risk considerations, and patient factors such as coagulopathy, inability to cooperate with breath-holding, severe emphysema for lung targets, and proximity of the lesion to major vascular or neural structures

• Understand the key differences between CT-guided and ultrasound-guided biopsy, including the absence of real-time needle visualization, the role of intermittent imaging for trajectory confirmation, increased radiation exposure, longer procedure times, and the greater importance of pre-procedural CT review and trajectory planning

• Recognize the most common CT-guided biopsy targets and their site-specific technical considerations, including lung nodules and masses, liver lesions, adrenal masses, retroperitoneal and pelvic lymph nodes, osseous and spinal lesions, pancreatic masses, and mediastinal targets

• Understand pre-procedural planning on CT, including lesion characterization, identification of the shortest safe needle path, recognition of structures to avoid along the trajectory such as vessels, bowel, pleura, and nerve roots, and the use of multiplanar reconstructions to plan angulated approaches

• Distinguish between FNA and core needle biopsy in the CT-guided setting, including when aspiration cytology alone is sufficient versus when larger core specimens are required for histologic architecture, immunohistochemistry, molecular profiling, or microbial culture

• Walk through the step-by-step CT-guided biopsy procedure, including patient positioning and immobilization, skin entry site selection and marking, local anesthesia, initial needle placement with confirmatory CT imaging, incremental needle advancement with interval imaging, final tip confirmation within the target lesion, specimen acquisition, needle removal, and post-biopsy imaging to assess for immediate complications

• Understand breath-hold technique and patient coaching for thoracic and upper abdominal targets, including the importance of consistent respiratory phase during imaging and needle advancement, strategies for coaching cooperative patients, and alternative approaches for patients unable to reliably hold their breath

• Recognize advanced guidance technologies including CT fluoroscopy for near-real-time needle visualization, cone-beam CT in the angiography suite for hybrid procedures, and electromagnetic navigation systems for lung nodule targeting — and understand the tradeoffs of each in terms of radiation dose, spatial resolution, and procedural complexity

• Understand coaxial technique in the CT-guided setting, including the advantages of placing a coaxial introducer needle at the lesion margin to allow multiple passes through a single skin puncture, reduce the risk of track seeding, and permit specimen acquisition from different areas within a heterogeneous lesion

• Identify procedural and post-procedural complications specific to each biopsy site, including pneumothorax and pulmonary hemorrhage for lung biopsies, hemorrhage and bile leak for hepatic biopsies, pancreatitis for pancreatic sampling, neurologic injury for spinal biopsies, and adrenal crisis for adrenal lesions — and understand how each is recognized, monitored, and managed

• Understand post-procedure imaging and monitoring protocols, including the routine post-lung biopsy chest radiograph for pneumothorax surveillance, observation periods specific to target organ and patient risk, criteria for chest tube placement versus observation in pneumothorax, and discharge instructions

• Recognize the causes of non-diagnostic results in CT-guided biopsy, including sampling of necrotic or fibrotic tissue, targeting error on intermittent imaging, lesion movement between imaging acquisitions, and suboptimal specimen processing — and understand the clinical decision-making around repeat biopsy, alternative modality guidance, or surgical referral